
Antiviral Drug Developer
Today, Gilead Sciences issued an internal email announcing that Jin Fangqian will join the company on March 8 as Vice President, Global, and General Manager, China.
Jin Fangqian previously served as General Manager of Abbott’s pharmaceutical business in China before joining Gilead Sciences. His resignation was announced on January 27, with his last working day being March 5. [Related Reading:Abbott’s General Manager for China Pharmaceutical Business, Jin Fangqian, Steps Down】
Prior to Jin Fangqian joining Gilead, Luo Yongqing served as the General Manager of Gilead China. Luo announced his resignation in August 2020, with his last working day at Gilead being September 10. Thereafter, Jacopo Andreose, Senior Vice President of Global Intercontinental Operations at Gilead, temporarily assumed responsibility for the China team and business. [Related Reading:Gilead China’s General Manager Luo Yongqing Departs; Successor Search Underway】
*Disclaimer: This article was written by an author contributing to Sina Medical News. The views expressed are solely those of the author and do not represent the position of Sina Medical News.